Efficacy and safety of Zicuiyin decoction on diabetic kidney disease: A multicenter, randomized controlled trial

Intestinal microbiota and diabetic kidney diseases: role of microbiota and derived metabolites in the modulation of renal inflammation and disease progression

(2021) C.M. Mosterd et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy and safety of Huangkui capsule for diabetic nephropathy

(2021) Wenrong An et al.   MEDICINE

Data Mining-Based Analysis of Chinese Medicinal Herb Formulae in Chronic Kidney Disease Treatment

(2020) Ping Xia et al.   Evidence-based Complementary and Alternative Medicine

Loganin and catalpol exert cooperative ameliorating effects on podocyte apoptosis upon diabetic nephropathy by targeting AGEs-RAGE signaling

(2020) Yuping Chen et al.   LIFE SCIENCES

Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease

(2019) Koichi Kikuchi et al.   Nature Communications

Astragalus membranaceus (Huang Qi) as adjunctive therapy for diabetic kidney disease: An updated systematic review and meta-analysis

(2019) La Zhang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

(2019) Andrew S. Levey et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling

(2018) Wenbei Han et al.   PHYTOMEDICINE

Rehmanniae Radix in osteoporosis: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology

(2017) Chenyue Liu et al.   JOURNAL OF ETHNOPHARMACOLOGY

Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014

(2016) Maryam Afkarian et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

(2014) Katherine R. Tuttle et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Expansion of Urease- and Uricase-Containing, Indole- and p-Cresol-Forming and Contraction of Short-Chain Fatty Acid-Producing Intestinal Microbiota in ESRD

(2014) Jakk Wong et al.   AMERICAN JOURNAL OF NEPHROLOGY

Efficacy and safety of Flos Abelmoschus manihot (Malvaceae) on type 2 diabetic nephropathy: A systematic review

(2014) Yi-zhi Chen et al.   Chinese Journal of Integrative Medicine

Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ROS/Akt/NF-κB pathway under high glucose conditions

(2014) LI SUN et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Kidney Disease and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

(2013) Ian H. de Boer et al.   DIABETES CARE

Nephrology in China

(2013) Zhi-Hong Liu   Nature Reviews Nephrology

Intestinal MicrobiOMICS to Define Health and Disease in Human and Mice

(2012) Matteo Serino et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Chronic kidney disease alters intestinal microbial flora

(2012) Nosratola D. Vaziri et al.   KIDNEY INTERNATIONAL

Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States

(2011) Ian H. de Boer   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Inhibitory Effects of Two Major Isoflavonoids in Radix Astragali on High Glucose-Induced Mesangial Cells Proliferation and AGEs-Induced Endothelial Cells Apoptosis

(2010) Dan Tang et al.   PLANTA MEDICA